MoonLake Immunotherapeutics
Vente netteMLTX·US·🇺🇸 US
0%achats·100%ventes
30 transactions$0Total achats·0 achat
$629.6MTotal ventes·30 ventes
1010 insiders
Dernier : 31 mars 2026
| Date | Insider | Type | Valeur | |
|---|---|---|---|---|
| 10 avr.+1j | Bodenstedt Matthias·Class A ordinary shares, par value $0.0001 per share | VenteP | $38K | |
| 9 avr.+2j | Bodenstedt Matthias·Class A ordinary shares, par value $0.0001 per share | VenteP | $1.6M | |
| 31 mars+2j | LAMPERT MARK NBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | LAMPERT MARK NBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | LAMPERT MARK NBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BVF INC/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BVF INC/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BVF INC/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BVF GP HOLDINGS LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BVF GP HOLDINGS LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BVF GP HOLDINGS LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BVF Partners OS Ltd.BOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BVF Partners OS Ltd.BOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BVF Partners OS Ltd.BOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | Biotechnology Value Trading Fund OS LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | Biotechnology Value Trading Fund OS LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | Biotechnology Value Trading Fund OS LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BVF II GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BVF II GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BVF II GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BIOTECHNOLOGY VALUE FUND II LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BIOTECHNOLOGY VALUE FUND II LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BIOTECHNOLOGY VALUE FUND II LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BVF I GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BVF I GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BVF I GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BIOTECHNOLOGY VALUE FUND L PBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M | |
| 31 mars+2j | BIOTECHNOLOGY VALUE FUND L PBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $26.3M | |
| 31 mars+2j | BIOTECHNOLOGY VALUE FUND L PBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $32.4M | |
| 31 mars+2j | BVF PARTNERS L P/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Vente | $4.2M |